| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $24.69K | $38.04K | $43.95K | $140.03M | $26.71K |
| R&D | – | – | – | – | – |
| SG&A | – | $0.00 | $50.00 | $0.00 | $125.00 |
| Operating Income | -$24.69K | -$38.04K | -$43.95K | -$104.03M | -$26.71K |
| Interest Expense | $49.91K | $52.55K | $58.63K | $57.04K | $89.83K |
| Tax Expense | – | – | – | – | – |
| Net Income | $8.98K | -$90.59K | -$102.58K | -$140.09M | -$116.54K |
| EPS (basic) | 0.0000 | 0.0000 | – | – | – |
| EPS (diluted) | 0.0000 | – | – | – | – |
| Shares (diluted) | $43.03M | – | – | – | – |